Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Preisler

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
Microscopy Research and Technique|July 13, 2000
Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: a new role for TNF alpha?S Sivaraman, C G Deshpande, R Ranganathan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Clonogenic potential of myeloid leukaemia cells in vitro is restricted to leukaemia cells expressing the CD34 antigenM Yin, F F Silvestri, S D Banavali, et al.
International Journal of Hematology|May 1, 1999
The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrowsS Mundle, P Venugopal, V Shetty, et al.
Leukemia & Lymphoma|May 1, 1993
Long-term outcome of patients with acute myelogenous leukemia: the role of maintenance therapy, consolidation therapy and the predictive value of two in vitro assaysA Raza, H D Preisler, G P Browman, et al.
Leukemia Research|June 1, 1997
Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phaseH Handa, U P Hegde, V M Kotelnikov, et al.
Cancer Treatment Reports|April 1, 1986
Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup StudyW R Vogler, H D Preisler, E F Winton, et al.
Leukemia & Lymphoma|May 30, 2001
High remission rate in acute myeloblastic leukemia with only two days of chemotherapyH D Preisler, P Venugopal, S A Gregory, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Cell kinetics of head and neck cancersV M Kotelnikov, I V Coon JS, A Haleem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Continued malignant cell proliferation in head and neck tumors during cytotoxic therapyH D Preisler, V M Kotelnikov, S LaFollette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosisV M Kotelnikov, J S Coon, S Mundle, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
Microscopy Research and Technique|July 13, 2000
Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: a new role for TNF alpha?S Sivaraman, C G Deshpande, R Ranganathan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Clonogenic potential of myeloid leukaemia cells in vitro is restricted to leukaemia cells expressing the CD34 antigenM Yin, F F Silvestri, S D Banavali, et al.
International Journal of Hematology|May 1, 1999
The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrowsS Mundle, P Venugopal, V Shetty, et al.
Leukemia & Lymphoma|May 1, 1993
Long-term outcome of patients with acute myelogenous leukemia: the role of maintenance therapy, consolidation therapy and the predictive value of two in vitro assaysA Raza, H D Preisler, G P Browman, et al.
Leukemia Research|June 1, 1997
Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phaseH Handa, U P Hegde, V M Kotelnikov, et al.
Cancer Treatment Reports|April 1, 1986
Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup StudyW R Vogler, H D Preisler, E F Winton, et al.
Leukemia & Lymphoma|May 30, 2001
High remission rate in acute myeloblastic leukemia with only two days of chemotherapyH D Preisler, P Venugopal, S A Gregory, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Cell kinetics of head and neck cancersV M Kotelnikov, I V Coon JS, A Haleem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Continued malignant cell proliferation in head and neck tumors during cytotoxic therapyH D Preisler, V M Kotelnikov, S LaFollette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosisV M Kotelnikov, J S Coon, S Mundle, et al.
Pageof 20